| Browse All

Dr. Reddy's Laboratories Limited (RDY)

Healthcare | Drug Manufacturers - Specialty & Generic | Hyderabad, India | NYSE
13.30 USD +0.24 (1.838%) ⇧ (April 17, 2026, 4 p.m. EDT)
After hours: 13.50 +0.20 (1.504%) ⇧ (April 17, 2026, 7:56 p.m. EDT)

Short-term: ★★☆☆☆ | Long-term: ★★★☆☆ | Dividends: ★★★☆☆
Hot Take | April 11, 2026, 4:15 p.m. EDT

Dr. Reddy's Laboratories Limited (RDY) is currently in a range-bound trading environment with a recent dip below the 50-day average. While the stock has shown some short-term volatility, the dividend yield is reasonably stable, and the company has a solid market cap. The options activity suggests a mix of bullish and bearish sentiment, but the lack of clear direction makes it a cautious play for short-term traders. For long-term investors, the stock's fundamentals and recent dip could present a buying opportunity, but the earnings growth is negative, which may affect long-term confidence.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.034507
AutoETS0.035675
AutoARIMA0.035675
AutoTheta0.037363

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 80%
H-stat 0.95
Ljung-Box p 0.000
Jarque-Bera p 0.237
Excess Kurtosis -1.05
Attribute Value
Sector Healthcare
Ex Dividend Date 2025-07-24
Last Dividend Date 2025-07-24
Debt to Equity Ratio 18.026
Revenue per Share 69.36662
Market Cap 11,104,117,760
Trailing P/E 17.97
Forward P/E 23.88
Beta 0.30
Profit Margins 16.36%
Website https://www.drreddys.com

As of April 11, 2026, 4:15 p.m. EDT: Options speculators are showing mixed signals. Calls are heavily positioned on the upside, particularly around the 15.0 strike, indicating potential bullish sentiment for the longer term. However, the recent volatility and low IV suggest uncertainty. Puts are also showing some activity, especially around the 12.5 strike, which may indicate cautiousness or short-term bearishness. Overall, the options market is not clearly aligned on a direction, suggesting a wait-and-see approach.


Dividend Data

Yield Summary
Last Yield 1yr Yield 3yr Avg 5yr Avg
0.62% 0.62% 0.91% 1.05%
Dividend History
Date Dividend Yield %
2025-07-25 0.0910 0.620314
2024-07-30 0.0958 0.597770
2023-07-28 0.0976 0.717806
2023-07-07 0.0976 0.797269
2022-08-01 0.0756 0.754374
2022-07-08 0.0774 0.719874
2021-07-30 0.0672 0.559887
2021-07-08 0.0684 0.486843
2020-07-10 0.0660 0.667904
2019-07-12 0.0574 0.800965
2018-07-13 0.0594 0.953670
2017-07-13 0.0620 0.801047
2016-07-14 0.0594 0.597637
2015-07-08 0.0624 0.584381
2014-08-01 0.0606 0.745355
2013-07-10 0.0528 0.777498
2012-06-27 0.0458 0.895023
2011-06-29 0.0502 0.808812
2011-06-14 0.1304 2.115084
2010-06-30 0.0480 0.895177
2009-07-02 0.0262 0.897333
2008-07-03 0.0196 0.753948
2007-07-06 0.0184 0.652965
2006-07-07 0.0109 0.456623
2005-07-07 0.0115 0.774304
2004-07-15 0.0109 0.754081
2003-08-07 0.0107 0.559872
2002-08-08 0.0052 0.344632
2001-11-20 0.0100 0.675742
Additional Data
dividendRate 0.09
dividendYield 0.69
exDividendDate 2025-07-25
trailingAnnualDividendRate 8.0
trailingAnnualDividendYield 0.6125574
lastDividendValue 0.091
lastDividendDate 2025-07-25
dividendDate 2025-08-06

Info Dump

Attribute Value
52 Week Change -0.044623256
Address1 8-2-337, Road No. 3
Address2 Banjara Hills
All Time High 16.892
All Time Low 1.004
Ask 13.96
Ask Size 5,200
Average Analyst Rating 2.6 - Hold
Average Daily Volume10 Day 2,301,570
Average Daily Volume3 Month 2,178,383
Average Volume 2,178,383
Average Volume10Days 2,301,570
Beta 0.302
Bid 13.21
Bid Size 3,800
Book Value 0.78664297
City Hyderabad
Compensation As Of Epoch Date 1,767,139,200
Country India
Crypto Tradeable 0
Currency USD
Current Price 13.3
Current Ratio 1.88
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 13.585
Day Low 13.29
Debt To Equity 18.026
Display Name Dr. Reddy's Laboratories
Dividend Date 1,754,438,400
Dividend Rate 0.09
Dividend Yield 0.69
Earnings Call Timestamp End 1,769,004,000
Earnings Call Timestamp Start 1,769,004,000
Earnings Growth -0.143
Earnings Quarterly Growth -0.144
Earnings Timestamp 1,778,589,000
Earnings Timestamp End 1,778,589,000
Earnings Timestamp Start 1,778,589,000
Ebitda 84,786,003,968
Ebitda Margins 0.24517
Enterprise To Ebitda -0.005
Enterprise To Revenue -0.001
Enterprise Value -393,843,072
Eps Current Year 56.33
Eps Forward 0.55690956
Eps Trailing Twelve Months 0.74
Esg Populated 0
Ex Dividend Date 1,753,401,600
Exchange NYQ
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 13.9558
Fifty Day Average Change -0.65579987
Fifty Day Average Change Percent -0.046991207
Fifty Two Week Change Percent -4.4623256
Fifty Two Week High 16.17
Fifty Two Week High Change -2.87
Fifty Two Week High Change Percent -0.17748918
Fifty Two Week Low 12.81
Fifty Two Week Low Change 0.48999977
Fifty Two Week Low Change Percent 0.038251348
Fifty Two Week Range 12.81 - 16.17
Financial Currency INR
First Trade Date Milliseconds 986,995,800,000
Five Year Avg Dividend Yield 0.72
Float Shares 599,157,698
Forward Eps 0.55690956
Forward P E 23.881796
Free Cashflow 13,468,874,752
Full Exchange Name NYSE
Full Time Employees 27,811
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.55182
Gross Profits 190,835,998,720
Has Pre Post Market Data 1
Held Percent Insiders 0.0
Held Percent Institutions 0.13442001
Implied Shares Outstanding 834,896,062
Industry Drug Manufacturers - Specialty & Generic
Industry Disp Drug Manufacturers - Specialty & Generic
Industry Key drug-manufacturers-specialty-generic
Is Earnings Date Estimate 0
Language en-US
Last Dividend Date 1,753,401,600
Last Dividend Value 0.091
Last Fiscal Year End 1,743,379,200
Last Split Date 1,730,764,800
Last Split Factor 5:1
Long Business Summary Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Long Name Dr. Reddy's Laboratories Limited
Market us_market
Market Cap 11,104,117,760
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_881725
Most Recent Quarter 1,767,139,200
Net Income To Common 56,587,001,856
Next Fiscal Year End 1,774,915,200
Non Diluted Market Cap 10,888,058,714
Number Of Analyst Opinions 5
Open 13.31
Operating Cashflow 63,105,998,848
Operating Margins 0.16420999
Payout Ratio 0.1182
Peg Ratio 3.56
Phone 91 40 4900 2900
Post Market Change 0.19999981
Post Market Change Percent 1.503758
Post Market Price 13.5
Post Market Time 1,776,470,189
Previous Close 13.06
Price Eps Current Year 0.23610865
Price Hint 2
Price To Book 16.90729
Price To Sales Trailing12 Months 0.032108508
Profit Margins 0.16363001
Quick Ratio 1.18
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key hold
Recommendation Mean 2.6
Region US
Regular Market Change 0.24
Regular Market Change Percent 1.83767
Regular Market Day High 13.585
Regular Market Day Low 13.29
Regular Market Day Range 13.29 - 13.585
Regular Market Open 13.31
Regular Market Previous Close 13.06
Regular Market Price 13.3
Regular Market Time 1,776,456,003
Regular Market Volume 1,727,542
Return On Assets 0.079569995
Return On Equity 0.161
Revenue Growth 0.044
Revenue Per Share 69.36662
Sand P52 Week Change 0.36506534
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 832,594,805
Shares Percent Shares Out 0.0176
Shares Short 14,646,750
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 13,476,363
Short Name Dr. Reddy's Laboratories Ltd
Short Percent Of Float 0.0342
Short Ratio 6.63
Source Interval 15
Symbol RDY
Target High Price 16.936052
Target Low Price 11.279665
Target Mean Price 14.414625
Target Median Price 14.173634
Total Cash 82,588,999,680
Total Cash Per Share 99.198
Total Debt 67,732,000,768
Total Revenue 345,831,014,400
Tradeable 0
Trailing Annual Dividend Rate 8.0
Trailing Annual Dividend Yield 0.6125574
Trailing Eps 0.74
Trailing P E 17.972973
Trailing Peg Ratio 3.5576
Triggerable 1
Two Hundred Day Average 14.06465
Two Hundred Day Average Change -0.7646494
Two Hundred Day Average Change Percent -0.054366756
Type Disp Equity
Volume 1,727,542
Website https://www.drreddys.com
Zip 500,034